Taclonex and Locoid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Taclonex (betamethasone dipropionate; calcipotriene hydrate) and Locoid (hydrocortisone butyrate). Common drug interactions include arthralgia among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Taclonex and Locoid. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Taclonex?

Taclonex has active ingredients of betamethasone dipropionate; calcipotriene hydrate. It is often used in psoriasis. eHealthMe is studying from 1,618 Taclonex users. Check the latest studies of Taclonex.

What is Locoid?

Locoid has active ingredients of hydrocortisone butyrate. eHealthMe is studying from 1,996 Locoid users. Check the latest studies of Locoid.

On Jul, 06, 2026

14 people who take Taclonex and Locoid together, and have interactions are studied.

What are the common drug interactions of Taclonex and Locoid, by gender? *:

female:

Arthralgia (joint pain)
Asthenia (weakness)
Drug ineffective
Myalgia (muscle pain)
Pain
Injection site bruising
Injection site haemorrhage (bleeding from injection site)

male:

Headache (pain in head)
Alanine aminotransferase increased
Hypertension (high blood pressure)
Hypoaesthesia (reduced sense of touch or sensation)
Lymphadenopathy (disease or enlargement of lymph nodes)
Meningioma benign (non cancer tumour of membranes that cover the brain and spinal cord just inside the skull)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

What are the common drug interactions of Taclonex and Locoid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alanine aminotransferase increased
Blood glucose increased
Injection site bruising
Injection site haemorrhage (bleeding from injection site)

40-49:

Headache (pain in head)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

50-59:

Hypoaesthesia (reduced sense of touch or sensation)
Lymphadenopathy (disease or enlargement of lymph nodes)
Meningioma benign (non cancer tumour of membranes that cover the brain and spinal cord just inside the skull)
Nasopharyngitis (inflammation of the nasopharynx)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Visual impairment
B-cell small lymphocytic lymphoma stage iii (blood cancer affecting b cells stage iii)
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)

60+:

Arthralgia (joint pain)
Asthenia (weakness)
Drug ineffective
Myalgia (muscle pain)
Pain
Anaemia (lack of blood)
Colitis (inflammation of colon)
Gastritis haemorrhagic (inflammation of stomach with bleeding)

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Urinary Tract Disorder: 1 person, 7.14%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.14%
Stress And Anxiety: 1 person, 7.14%
Stable Angina (a constant chest pain): 1 person, 7.14%
Seasonal Allergy (allergic condition due to certain season): 1 person, 7.14%
Rickets (softening of bones): 1 person, 7.14%
Itching: 1 person, 7.14%
Insomnia (sleeplessness): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Taclonex and Locoid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously